Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Poliovirus Receptor anticorps (AA 220-345)

PVR Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7163737
  • Antigène Voir toutes Poliovirus Receptor (PVR) Anticorps
    Poliovirus Receptor (PVR)
    Épitope
    • 14
    • 8
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 220-345
    Reactivité
    • 54
    • 16
    • 5
    • 1
    Humain
    Hôte
    • 43
    • 12
    • 10
    Lapin
    Clonalité
    • 40
    • 24
    • 1
    Polyclonal
    Conjugué
    • 33
    • 6
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Poliovirus Receptor est non-conjugé
    Application
    • 34
    • 24
    • 20
    • 10
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
     Réactivité croisée
    Humain, Souris
    Purification
    Antigen Affinity Purified
    Immunogène
    Recombinant Human Poliovirus receptor protein (220-345AA)
    Isotype
    IgG
    Top Product
    Discover our top product PVR Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Poliovirus Receptor (PVR)
    Autre désignation
    PVR (PVR Produits)
    Synonymes
    anticorps PVR, anticorps CD155, anticorps HVED, anticorps NECL5, anticorps Necl-5, anticorps PVS, anticorps TAGE4, anticorps 3830421F03Rik, anticorps D7Ertd458e, anticorps Taa1, anticorps Tage4, anticorps mE4, anticorps necl-5, anticorps poliovirus receptor, anticorps PVR, anticorps Pvr
    Sujet

    Background: Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration. Serves as a receptor for poliovirus attachment to target cells. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport.2 Publications

    Aliases: CD155 antibody, CD155 antigen antibody, FLJ25946 antibody, HVED antibody, mE4 antibody, NECL 5 antibody, Necl-5 antibody, Necl5 antibody, Nectin like 5 antibody, Nectin like protein 5 antibody, Nectin-like protein 5 antibody, Ortholog of mouse Tage4 antibody, Poliovirus receptor antibody, PVR antibody, PVR_HUMAN antibody, PVS antibody, Taa1 antibody, Tage 4 antibody, TAGE4 antibody

    UniProt
    P15151
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
Vous êtes ici:
Support technique